OHSU

SCC Research

Research Studies

cell phone

The Smoking Cessation Center has multiple, ongoing research studies primarily investigating new medications for treatment of tobacco dependence.


 

 


Active Trials:

  • Pfizer - A Phase 4 Randomized Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Neuropsychiatric Safety and Efficacy of 12 Weeks Varenicline Tartrate 1MG BID and Bupropion Hydrochloride 150 MB BID for Smoking Cessation in Subjects With and Without a History of Psychiatric Disorders:
    David Gonzales, PhD, Principal Investigator
  • Analysis of predictors of smoking abstinence after discharge from the OHSU hospital.
    Wendy Bjornson, MPH Principal Investigator

Past Research Studies

View our Past Research Studies Archive


Smoking Cessation Center Research Publications

stack of books

The faculty of the Smoking Cessation Center at OHSU have published many articles on smoking cessation and related topics. 

View the Smoking Cessation Center Research Publications